{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:49:01Z","timestamp":1773888541653,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bcmd.2024.102837","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T05:42:18Z","timestamp":1707975738000},"page":"102837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Rare bleeding disorders: Real-world data from a Spanish tertiary hospital"],"prefix":"10.1016","volume":"106","author":[{"given":"Daniel","family":"Mart\u00ednez-Carballeira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Caro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Corte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Carlos","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel Asunci\u00f3n","family":"Hern\u00e1ndez de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2024.102837_bb0005","doi-asserted-by":"crossref","unstructured":"Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004 Sep 1;104(5):1243\u201352. doi: https:\/\/doi.org\/10.1182\/blood-2004-02-0595. Epub 2004 May 11. PMID: 15138162.","DOI":"10.1182\/blood-2004-02-0595"},{"issue":"4","key":"10.1016\/j.bcmd.2024.102837_bb0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0029-1225757","article-title":"Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and management","volume":"35","author":"Peyvandi","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.bcmd.2024.102837_bb0015","doi-asserted-by":"crossref","unstructured":"Palla R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood 2015 Mar 26;125(13):2052\u201361. doi: https:\/\/doi.org\/10.1182\/blood-2014-08-532820. Epub 2015 Feb 23. PMID: 25712993.","DOI":"10.1182\/blood-2014-08-532820"},{"issue":"2","key":"10.1016\/j.bcmd.2024.102837_bb0020","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1538-7836.2003.t01-1-00553.x","article-title":"Dimichele DM; north American rare bleeding disorder study group. Rare bleeding disorder registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias","volume":"2","author":"Acharya","year":"2004","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.bcmd.2024.102837_bb0025","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J Thromb Haemost."},{"issue":"20","key":"10.1016\/j.bcmd.2024.102837_bb0030","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1182\/bloodadvances.2020002740","article-title":"Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study","volume":"4","author":"Saes","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.bcmd.2024.102837_bb0035","doi-asserted-by":"crossref","unstructured":"Maas DPMSM, Saes JL, Blijlevens NMA, Cnossen MH, den Exter PL, Kruis IC, Meijer K, Nieuwenhuizen L, Peters M, Schutgens REG, van Heerde WL, Schols SEM; RBiN study group. Treatment of patients with rare bleeding disorders in the Netherlands: Real-life data from the RBiN study. J Thromb Haemost. 2022 Apr;20(4):833\u2013844. doi: https:\/\/doi.org\/10.1111\/jth.15652. Epub 2022 Feb 8. PMID: 35038781; PMCID: PMC9305774.","DOI":"10.1111\/jth.15652"},{"key":"10.1016\/j.bcmd.2024.102837_bb0040","doi-asserted-by":"crossref","unstructured":"Viswabandya A, Baidya S, Nair SC, Abraham A, George B, Mathews V, Chandy M, Srivastava A. Correlating clinical manifestations with factor levels in rare bleeding disorders: a report from southern India. Haemophilia 2012 May;18(3):e195-200. doi: https:\/\/doi.org\/10.1111\/j.1365-2516.2011.02730.x. Epub 2012 Jan 4. PMID: 22221743.","DOI":"10.1111\/j.1365-2516.2011.02730.x"},{"issue":"2","key":"10.1016\/j.bcmd.2024.102837_bb0045","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jha2.664","article-title":"VHrare study: prevalence, clinical features and management of severe rare bleeding disorders in a large cohort","volume":"4","author":"Ben\u00edtez Hidalgo","year":"2023","journal-title":"EJHaem"},{"issue":"6","key":"10.1016\/j.bcmd.2024.102837_bb0050","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1160\/TH07-01-0034","article-title":"International registry on factor XIII deficiency: a basis formed mostly on European data","volume":"97","author":"Ivaskevicius V, Seitz R, Kohler HP, Schroeder V, Muszbek L, Ariens RA, Seifried E, Oldenburg J; Study Group","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.bcmd.2024.102837_bb0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2516.2006.01303.x","article-title":"Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene","volume":"12","author":"Herrmann FH, Auerswald G, Ruiz-Saez A, Navarrete M, Pollmann H, Lopaciuk S, Batorova A, Wulff K; Greifswald Factor X Deficiency Study Group","year":"2006","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.bcmd.2024.102837_bb0060","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2516.2008.01910.x","article-title":"Salazar-Sanchez L; Greifswald factor FVII deficiency study group. Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene","volume":"15","author":"Herrmann","year":"2009","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.bcmd.2024.102837_bb0065","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1538-7836.2009.03329.x","article-title":"Major differences in bleeding symptoms between factor VII deficiency and hemophilia B","volume":"7","author":"Bernardi F, Dolce A, Pinotti M, Shapiro AD, Santagostino E, Peyvandi F, Batorova A, Lapecorella M, Schved JF, Ingerslev J, Mariani G; International Factor VII Deficiency Study Group","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.bcmd.2024.102837_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29545","article-title":"Pediatric severe factor XI deficiency: a multicenter study","volume":"69","author":"Barg","year":"2022","journal-title":"Pediatr. Blood Cancer"},{"issue":"2","key":"10.1016\/j.bcmd.2024.102837_bb0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0038-1653750","article-title":"Definition of the bleeding tendency in factor XI-deficient kindreds--a clinical and laboratory study","volume":"73","author":"Bolton-Maggs","year":"1995","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.bcmd.2024.102837_bb0080","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1538-7836.2006.02014.x","article-title":"Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemia","volume":"4","author":"Peyvandi","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.bcmd.2024.102837_bb0085","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/j.1538-7836.2012.04844.x","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2024.102837_bb0090","doi-asserted-by":"crossref","unstructured":"Bolton-Maggs PH, Perry DJ, Chalmers EA, Parapia LA, Wilde JT, Williams MD, Collins PW, Kitchen S, Dolan G, Mumford AD. The rare coagulation disorders--review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004 Sep;10(5):593\u2013628. doi: https:\/\/doi.org\/10.1111\/j.1365-2516.2004.00944.x. (PMID: 15357789).","DOI":"10.1111\/j.1365-2516.2004.00944.x"},{"issue":"3","key":"10.1016\/j.bcmd.2024.102837_bb0095","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.13058","article-title":"Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors\u2019 Organization guideline on behalf of the British Committee for Standards in Haematology","volume":"167","author":"Mumford","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2024.102837_bb0100","doi-asserted-by":"crossref","unstructured":"Menegatti M, Peyvandi F. Treatment of rare factor deficiencies other than hemophilia. Blood 2019 Jan 31;133(5):415\u2013424. doi: https:\/\/doi.org\/10.1182\/blood-2018-06-820738. Epub 2018 Dec 17. PMID: 30559262.","DOI":"10.1182\/blood-2018-06-820738"},{"key":"10.1016\/j.bcmd.2024.102837_bb0105","doi-asserted-by":"crossref","unstructured":"Trossaert M, Chamouard V, Biron-Andreani C, Casini A, De Mazancourt P, De Raucourt E, Drillaud N, Frotscher B, Guillet B, Lebreton A, Roussel-Robert V, Rugeri L, Dargaud Y. Management of rare inherited bleeding disorders: proposals of the French reference Centre on Haemophilia and rare coagulation disorders. Eur. J. Haematol. 2023 Jun;110(6):584\u2013601. doi: https:\/\/doi.org\/10.1111\/ejh.13941. Epub 2023 Feb 20. PMID: 36748278.","DOI":"10.1111\/ejh.13941"},{"key":"10.1016\/j.bcmd.2024.102837_bb0110","doi-asserted-by":"crossref","unstructured":"Bolton-Maggs P, Goudemand J, Hermans C, Makris M, de Moerloose P. FXI concentrate use and risk of thrombosis. Haemophilia 2014 Jul;20(4):e349-51. doi: https:\/\/doi.org\/10.1111\/hae.12457. Epub 2014 May 2. PMID: 24785157.","DOI":"10.1111\/hae.12457"},{"key":"10.1016\/j.bcmd.2024.102837_bb0115","doi-asserted-by":"crossref","unstructured":"Peyvandi F, Kunicki T, Lillicrap D. Genetic sequence analysis of inherited bleeding diseases. Blood. 2013 Nov 14;122(20):3423\u201331. doi: https:\/\/doi.org\/10.1182\/blood-2013-05-505511. Epub 2013 Oct 11. PMID: 24124085; PMCID: PMC4260973.","DOI":"10.1182\/blood-2013-05-505511"},{"key":"10.1016\/j.bcmd.2024.102837_bb0120","doi-asserted-by":"crossref","unstructured":"Menegatti M, Palla R. Clinical and laboratory diagnosis of rare coagulation disorders (RCDs). Thromb. Res. 2020 Dec;196:603\u2013608. doi: https:\/\/doi.org\/10.1016\/j.thromres.2019.09.006. Epub 2019 Sep 7. PMID: 31515069.","DOI":"10.1016\/j.thromres.2019.09.006"},{"issue":"7","key":"10.1016\/j.bcmd.2024.102837_bb0125","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood.V84.7.2214.2214","article-title":"Molecular analysis of polish patients with factor VII deficiency","volume":"84","author":"Arbini","year":"1994","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.bcmd.2024.102837_bb0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cca.2009.09.007","article-title":"Phenotypic and genotypic characterization of factor VII deficiency patients from Western India","volume":"409","author":"Mota","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bcmd.2024.102837_bb0135","doi-asserted-by":"crossref","unstructured":"Rabelo FY, Jardim LL, Landau MB, Gadelha T, Corr\u00eaa MF, Pereira IF, Rezende SM. The molecular basis of low activity levels of coagulation factor VII: a Brazilian cohort. Haemophilia 2015 Sep;21(5):670-80. doi: https:\/\/doi.org\/10.1111\/hae.12645. Epub 2015 Mar 31. PMID: 25828579.","DOI":"10.1111\/hae.12645"},{"key":"10.1016\/j.bcmd.2024.102837_bb0140","doi-asserted-by":"crossref","unstructured":"Esteban J, de la Morena-Barrio ME, Salloum-Asfar S, Padilla J, Mi\u00f1ano A, Rold\u00e1n V, Soria JM, Vidal F, Corral J, Vicente V. High incidence of FXI deficiency in a Spanish town caused by 11 different mutations and the first duplication of F11: results from the Yecla study. Haemophilia 2017 Nov;23(6):e488-e496. doi: https:\/\/doi.org\/10.1111\/hae.13356. Epub 2017 Sep 27. PMID: 28960694.","DOI":"10.1111\/hae.13356"},{"key":"10.1016\/j.bcmd.2024.102837_bb0145","doi-asserted-by":"crossref","unstructured":"Mitchell M, Mountford R, Butler R, Alhaq A, Dai L, Savidge G, Bolton-Maggs PH. Spectrum of factor XI (F11) mutations in the UK population--116 index cases and 140 mutations. Hum. Mutat. 2006 Aug;27(8):829. doi: https:\/\/doi.org\/10.1002\/humu.9439. (PMID: 16835901).","DOI":"10.1002\/humu.9439"},{"key":"10.1016\/j.bcmd.2024.102837_bb0150","doi-asserted-by":"crossref","unstructured":"Caron C, Meley R, Le Cam Duchez V, Aillaud MF, Lavenu-Bombled C, Dutrillaux F, Flaujac C, Ryman A, Ternisien C, Lasne D, Galinat H, Pouplard C. Agreement between factor XIII activity and antigen assays in measurement of factor XIII: a French multicenter study of 147 human plasma samples. Int. J. Lab. Hematol. 2017 Jun;39(3):279-285. doi: https:\/\/doi.org\/10.1111\/ijlh.12621. Epub 2017 Mar 20. PMID: 28318109.","DOI":"10.1111\/ijlh.12621"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979624000159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979624000159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:37:13Z","timestamp":1761050233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979624000159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":30,"alternative-id":["S1079979624000159"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2024.102837","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rare bleeding disorders: Real-world data from a Spanish tertiary hospital","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2024.102837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 University of Oviedo. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102837"}}